GEA
BNGO icon

Glen Eagle Advisors’s Bionano Genomics BNGO Stock Holding History

Glen Eagle Advisors’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1
Closed -$1.22K – 1096
2022
Q4 		$1.22K Hold
1
– – ﹤0.01% 986
2022
Q3 		$1.53K Hold
1
– – ﹤0.01% 911
2022
Q2 		$1.15K Hold
1
– – ﹤0.01% 890
2022
Q1 		$2.15K Hold
1
– – ﹤0.01% 797
2021
Q4 		$2.5K Hold
1
– – ﹤0.01% 790
2021
Q3 		$4.59K Hold
1
– – ﹤0.01% 829
2021
Q2 		$6.12K Hold
1
– – ﹤0.01% 785
2021
Q1 		$6.75K Buy
+1
New +$5.64K ﹤0.01% 723

Other funds holding BNGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Glen Eagle Advisors's BNGO Position: Q1 2023 in Review

Glen Eagle Advisors sold out of Bionano Genomics (BNGO) in Q1 2023, closing a stake of 1 share — an estimated $1.22K sold.

Glen Eagle Advisors first reported a position in BNGO in Q1 2021 and held it in 8 quarters. The position peaked at $6.75K in Q1 2021. 126 funds tracked by Wall St. Rank hold BNGO as of Q1 2023.

  • Glen Eagle Advisors reported no remaining Bionano Genomics position as of Q1 2023 after selling out during the quarter.
  • Glen Eagle Advisors sold 1 Bionano Genomics share in Q1 2023, an estimated $1.22K.
  • Glen Eagle Advisors first reported a position in Bionano Genomics in Q1 2021 and held it in 8 quarters.
  • Glen Eagle Advisors's Bionano Genomics position peaked at $6.75K in Q1 2021.
  • 126 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2023.

Based on Glen Eagle Advisors's 13F filing for Q1 2023, filed 13 Aug 2024.